e 64 has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorelik, E; Jani, JP; Lazo, JS; Mistry, JS; Sebti, SM | 1 |
| Jani, JP; Lazo, JS; Mistry, JS; Morris, G; Sebti, SM | 1 |
2 other study(ies) available for e 64 and Cancer of Head
| Article | Year |
|---|---|
Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
Topics: Animals; Bleomycin; Burkitt Lymphoma; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Damage; Drug Resistance; Glycoside Hydrolases; Head and Neck Neoplasms; Humans; Inactivation, Metabolic; Leucine; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1991 |
Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
Topics: Bleomycin; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cysteine Proteinase Inhibitors; Drug Resistance; Drug Synergism; Head and Neck Neoplasms; Leucine; Leupeptins; Tumor Cells, Cultured | 1991 |